Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) Net Margin Growth (1y) (2012 - 2026)

Analysis

Abeona Therapeutics (ABEO) Net Margin Growth (1y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -763.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 529.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4,168.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 673.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2,208.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -392.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 29,636.00
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn -3.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.13 Mn
Jun 30, 2023 31,207.00
Dec 31, 2018 89,648.00
Sep 30, 2018 147,899.00
Jun 30, 2018 -62,066.00
Mar 31, 2018 83,792.00
Dec 31, 2017 -289,818.00
Sep 30, 2017 -101,364.00
Jun 30, 2017 -68,296.00
Mar 31, 2017 -46,182.00
Dec 31, 2016 -164,678.00
Sep 30, 2016 70,479.00
Jun 30, 2016 -167,373.00
Mar 31, 2016 -158,396.00
Dec 31, 2015 430,778.00
Sep 30, 2015 -119,486.00
Jun 30, 2015 389,898.00
Mar 31, 2015 -1,366.00
Dec 31, 2014 822,692.00
Sep 30, 2014 -46,036.00